Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Jacobio Pharma to Present Data of Three Preclinical Studies at the 2023 AACR Annual Meeting 2023-03-15 10:45
Ascentage Pharma to Present Latest Results from Three Preclinical Studies at 2023 American Association for Cancer Research Annual Meeting 2023-03-15 07:59
Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011 2023-03-14 23:42
Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclonal Antibody, in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1 Trial in Advanced Solid Tumors and Cutaneous T-cell Lymphoma 2023-03-14 20:00
Patient Enrollment Completed for Phase III Clinical Trial of Akeso's Cadonilimab in Treatment of Gastric Cancer 2023-03-14 17:01
Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate Cell Therapy Development for Solid Tumors 2023-03-13 20:00
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing 2023-03-10 09:00
GenFleet Therapeutics to Present Phase I Data for GFH312 at 2023 American Society for Clinical Pharmacology & Therapeutics Meeting 2023-03-09 19:00
BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events 2023-03-08 22:47
Hovione receives the 2023 CDMO Leadership Award in all six categories and is Champion in Compatibility and Expertise 2023-03-08 22:00
MSCI ESG Updated I-Mab to "A" Rating 2023-03-07 21:02
AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract 2023-03-07 20:30
AnPac Bio-Medical Science Announces US$5 Million Private Placement 2023-03-06 21:30
HanAll Biopharma's Licensed Partner in China Announces Positive Topline Phase 3 Results for Batoclimab in Myasthenia Gravis 2023-03-06 20:00
Porton Advanced Collaborates with DanausGT to Accelerate the Development of Gene and Cell Therapy 2023-03-02 20:00
Sanyou Biopharmaceuticals opens Cambridge MA, US office, expanding its business outreach to a central hub of biotech network 2023-03-02 18:00
ExoCoBio obtained 2 GMP Licenses for Exosome Biopharmaceuticals from Korea MFDS and for Hyaluronic Acid (HA) Dermal Fillers from Brazil ANVISA 2023-03-02 14:09
GenFleet receives EMA approval for phase Ib/II study of GFH925 (KRAS G12C inhibitor) in combination with ERBITUX® (cetuximab) treating patients with advanced NSCLC in first-line setting 2023-03-01 19:00
First in Class, Mabwell Announces the TGA Approval of 9MW3811 for IND 2023-02-28 23:00
Gracell Biotechnologies to Participate in Oppenheimer 33rd Annual Healthcare Conference 2023-02-28 21:00
1 56 57 58 59 60 220